Tirzepatide vs. Semaglutide: Which Is Better for Weight Loss?

Tirzepatide produces greater average weight loss than semaglutide in direct head-to-head research, but "better" depends on your body, your side effects, and your insurance coverage. In the SURMOUNT-5 trial, adults with obesity lost about 20.2% of their body weight on tirzepatide versus about 13.7% on semaglutide over 72 weeks. Both drugs are FDA-approved for chronic weight management, and both work only while you keep taking them.

What the Head-to-Head Trial Data Shows

SURMOUNT-5 was the first major trial to compare these two drugs directly for weight loss in people who do not have type 2 diabetes. Tirzepatide came out ahead on every weight-loss endpoint measured, including the share of participants who lost at least 15% of their body weight.

Study	Comparison	Population	Length	Average weight loss
SURMOUNT-5	Tirzepatide vs. semaglutide	Adults with obesity, no diabetes	72 weeks	−20.2% vs. −13.7%
SURMOUNT-1	Tirzepatide 15 mg vs. placebo	Adults with obesity, no diabetes	72 weeks	−20.9% vs. −3.1%
STEP 1	Semaglutide 2.4 mg vs. placebo	Adults with obesity, no diabetes	68 weeks	−14.9% vs. −2.4%
SURPASS-2	Tirzepatide vs. semaglutide 1 mg	Adults with type 2 diabetes	40 weeks	Greater A1C and weight reduction with tirzepatide

These numbers are averages, not promises. A meaningful minority of people lose more weight on semaglutide than on tirzepatide, and no trial can predict what will happen in your body.

How the Two Drugs Work Differently

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it mimics two gut hormones instead of one.

Both slow stomach emptying, blunt appetite, and change how the brain registers fullness. The extra GIP activity is one leading explanation for the benefits of tirzepatide over semaglutide seen in average weight-loss results, though researchers are still working out exactly how much that matters.

Neither drug burns fat directly, and neither replaces protein intake, resistance training, or sleep. Rapid weight loss can cost lean muscle mass on either medication.

Ozempic vs. Mounjaro vs. Wegovy vs. Zepbound

Most of the online confusion comes from brand names, not molecules. Ozempic and Wegovy are the same drug (semaglutide). Mounjaro and Zepbound are the same drug (tirzepatide). The difference is what each product is approved to treat.

Brand	Active drug	Approved for	Form	Starting dose
Ozempic	Semaglutide	Type 2 diabetes	Weekly injection	0.25 mg
Wegovy	Semaglutide	Chronic weight management	Weekly injection	0.25 mg
Rybelsus	Semaglutide	Type 2 diabetes	Daily tablet	3 mg
Mounjaro	Tirzepatide	Type 2 diabetes	Weekly injection	2.5 mg
Zepbound	Tirzepatide	Chronic weight management	Weekly injection	2.5 mg

Someone asking what is tirzepatide for will get two answers depending on the brand: Mounjaro treats type 2 diabetes, and Zepbound treats obesity. That means the fair weight-loss comparison is Zepbound versus Wegovy, not Ozempic versus a drug approved only for diabetes.

Side Effects and Safety

Both drugs cause gastrointestinal side effects, most commonly nausea, vomiting, diarrhea, and constipation. These often ease as the dose stabilizes, but they are the top reason people stop treatment.

• Both carry a boxed warning about thyroid C-cell tumors seen in rodents and are contraindicated with a personal or family history of medullary thyroid cancer or MEN2.
• Serious but uncommon risks include pancreatitis, gallbladder disease, and gastroparesis.
• Heartburn, fatigue, and injection-site reactions are frequently reported but rarely dangerous.

The short answer to is tirz safe for weight loss is that FDA-approved tirzepatide has been studied in tens of thousands of adults and has a documented risk profile, while compounded and gray-market versions sold online do not. Online chatter about peptides for weight loss side effects often traces back to those unregulated products rather than to approved medications. Talk with a healthcare professional before starting, stopping, or switching drugs.

Dosing and Titration

Both drugs start low and step up slowly to limit side effects. The starting dose of semaglutide for weight loss is 0.25 mg once weekly for four weeks, then 0.5 mg, and so on. Tirzepatide starts at 2.5 mg weekly and follows a similar schedule.

Doctors follow a titration plan, which is why increase dose of semaglutide for weight loss typically happens every four weeks until a maintenance dose is reached. Rushing that schedule usually makes nausea worse, not results better.

If injections are a barrier, semaglutide oral for weight loss is the closest thing to an option in this drug class today, but the approved oral product (Rybelsus) is for type 2 diabetes rather than obesity.

Cost, Coverage, and Access

Without insurance, list prices for both drugs run above $1,000 per month, although manufacturer cash-pay vials and savings programs have pushed some options into the $350 to $500 range. Prices and programs change often, so verify current numbers before budgeting.

A drug that costs $25 a month with insurance will usually beat a slightly more effective drug that costs $1,000 out of pocket. Check your formulary, prior authorization rules, and any manufacturer savings card before deciding.

What Reddit and Real-World Users Report

Searches like tirzepatide vs ozempic reddit and semaglutide worked better than tirzepatide reddit return thousands of personal accounts. The pattern in those threads is genuinely mixed: many people report stronger appetite suppression and faster loss on tirzepatide, while others say semaglutide worked better for them or caused fewer side effects.

Personal stories are useful for setting expectations about side effects and daily life. They are not reliable for predicting your own results, because individual response varies widely.

Which One Is Actually Better for You?

1. For maximum average weight loss: tirzepatide has the stronger head-to-head trial numbers.
2. For cost and coverage: whichever drug your plan covers at the lowest out-of-pocket cost is usually the better real-world choice.
3. For tolerability: if one drug caused severe nausea, the other may suit you better — with a doctor's guidance.
4. For convenience: semaglutide is the only molecule in this class with an approved oral form, though not for weight loss.

Whichever you choose, both are long-term treatments. Weight regain after stopping is common with both drugs, so plan for ongoing care rather than a short course.

COMMON QUESTIONS

Frequently Asked Questions

Is tirzepatide or semaglutide better for weight loss?

Tirzepatide produces greater average weight loss in head-to-head trials, with about 20.2% body weight lost versus 13.7% for semaglutide over 72 weeks in SURMOUNT-5. However, individual results vary, and some people respond better to semaglutide. The better choice usually comes down to tolerability, cost, and insurance coverage.

Can I switch from semaglutide to tirzepatide if I am not losing weight?

Switching is possible with a prescriber's approval, and many clinicians do it when weight loss stalls or side effects are poorly tolerated. Doses do not transfer directly between the two drugs, so tirzepatide usually restarts at 2.5 mg weekly. Never switch or adjust doses on your own.

Are Ozempic and Mounjaro approved for weight loss?

No. Ozempic and Mounjaro are FDA-approved for type 2 diabetes, not for chronic weight management. The same active drugs are sold as Wegovy (semaglutide) and Zepbound (tirzepatide) for weight loss. Using a diabetes-branded product for weight loss is generally off-label unless your prescriber has a specific reason.